Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s13277-013-1544-y, but it redirected us to https://link.springer.com/article/10.1007/s13277-013-1544-y. The analysis below is for the second page.

Title[redir]:
Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk | Tumor Biology
Description:
The vitamin D receptor (VDR) can influence cancer susceptibility through binding to vitamin D. However, the previous studies were contradictory. Therefore this meta-analysis was conducted to clarify the association between VDR polymorphisms (BsmI, TaqI, FokI, and ApaI) and cancer risk. One hundred twenty-six studies were enrolled through PubMed. For VDR BsmI polymorphism, significantly increased cancer risks were observed in the overall analysis. In the further stratified analysis, increased risks were observed in colorectal and skin cancer, especially in Caucasian population. However, no significant associations were observed in other VDR polymorphisms in the overall analysis. In the further subgroup analysis, increased risks were found in oral, breast, and basal cell cancer while decreased risk was found in prostate cancer in t allele carriers of TaqI polymorphism. For VDR FokI polymorphism, increased risks were found in ovarian and skin cancer while decreased risk in glioma in f allele carriers. For VDR ApaI polymorphism, increased risk was observed in basal cell cancer, especially in Asian population in a allele carriers. In conclusion, these results indicated that b allele of BamI polymorphism was a risk factor for cancer susceptibility. Meanwhile, t allele of TaqI polymorphism was a risk factor for oral, breast, and basal cell cancer and a protective factor for prostate cancer. Moreover, f allele of FokI polymorphism was a risk factor for ovarian and skin cancer and a protective factor for glioma. Finally, a allele of ApaI polymorphism was a risk factor for basal cell cancer in Asian population.

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Business & Finance

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

πŸ™οΈ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 98,426,998 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We see no obvious way the site makes money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {πŸ”}

pubmed, cancer, article, vitamin, google, scholar, receptor, cas, risk, polymorphisms, gene, polymorphism, vdr, central, metaanalysis, breast, analysis, res, skin, cell, prostate, allele, ovarian, bone, nanjing, susceptibility, factor, epidemiol, privacy, cookies, content, taqi, foki, increased, basal, variants, chen, women, biomarkers, prev, data, information, publish, research, search, systematic, review, bangshun, studies, association,

Topics {βœ’οΈ}

month download article/chapter bueno-de-mesquita hb pathway including genome-wide postmenopausal mexican-american women early-onset breast cancer full article pdf vitamin d-related genes basal cell cancer brca1/2-mutation carrier privacy choices/manage cookies common genetic variants cultured skin fibroblasts jurutka pw article xu prostate cancer cells related subjects bone mineral density mol cell endocrinol shukui wang skin cancer risk environmental factors van leeuwen jp uitterlinden ag van duijnhoven fj bone miner res translation initiation codon healthy talents’ cultivation electronic supplementary material high resolution image nat rev cancer natl cancer inst conditions privacy policy article log common allelic variants systematic meta-analysis breast cancer res european economic area van meurs jb author information authors pathway gene variants functionally relevant polymorphisms accepting optional cookies african american women plasma parathyroid hormone translation initiation site influence cancer susceptibility epithelial ovarian cancer receptor chromosomal gene receptor gene contributes prostate cancer risk

Questions {❓}

  • Plasma parathyroid hormone, phosphatemia and vitamin D receptor genotype: are they interrelated?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk
         description:The vitamin D receptor (VDR) can influence cancer susceptibility through binding to vitamin D. However, the previous studies were contradictory. Therefore this meta-analysis was conducted to clarify the association between VDR polymorphisms (BsmI, TaqI, FokI, and ApaI) and cancer risk. One hundred twenty-six studies were enrolled through PubMed. For VDR BsmI polymorphism, significantly increased cancer risks were observed in the overall analysis. In the further stratified analysis, increased risks were observed in colorectal and skin cancer, especially in Caucasian population. However, no significant associations were observed in other VDR polymorphisms in the overall analysis. In the further subgroup analysis, increased risks were found in oral, breast, and basal cell cancer while decreased risk was found in prostate cancer in t allele carriers of TaqI polymorphism. For VDR FokI polymorphism, increased risks were found in ovarian and skin cancer while decreased risk in glioma in f allele carriers. For VDR ApaI polymorphism, increased risk was observed in basal cell cancer, especially in Asian population in a allele carriers. In conclusion, these results indicated that b allele of BamI polymorphism was a risk factor for cancer susceptibility. Meanwhile, t allele of TaqI polymorphism was a risk factor for oral, breast, and basal cell cancer and a protective factor for prostate cancer. Moreover, f allele of FokI polymorphism was a risk factor for ovarian and skin cancer and a protective factor for glioma. Finally, a allele of ApaI polymorphism was a risk factor for basal cell cancer in Asian population.
         datePublished:2014-01-10T00:00:00Z
         dateModified:2014-01-10T00:00:00Z
         pageStart:4153
         pageEnd:4169
         sameAs:https://doi.org/10.1007/s13277-013-1544-y
         keywords:
            Vitamin D receptor
            VDR
            Polymorphism
            Cancer risk
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig4_HTML.gif
         isPartOf:
            name:Tumor Biology
            issn:
               1423-0380
               1010-4283
            volumeNumber:35
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yeqiong Xu
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bangshun He
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuqin Pan
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiwen Deng
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huiling Sun
               affiliation:
                     name:Nanjing Normal University
                     address:
                        name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rui Li
               affiliation:
                     name:Nanjing Normal University
                     address:
                        name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tianyi Gao
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guoqi Song
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shukui Wang
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk
      description:The vitamin D receptor (VDR) can influence cancer susceptibility through binding to vitamin D. However, the previous studies were contradictory. Therefore this meta-analysis was conducted to clarify the association between VDR polymorphisms (BsmI, TaqI, FokI, and ApaI) and cancer risk. One hundred twenty-six studies were enrolled through PubMed. For VDR BsmI polymorphism, significantly increased cancer risks were observed in the overall analysis. In the further stratified analysis, increased risks were observed in colorectal and skin cancer, especially in Caucasian population. However, no significant associations were observed in other VDR polymorphisms in the overall analysis. In the further subgroup analysis, increased risks were found in oral, breast, and basal cell cancer while decreased risk was found in prostate cancer in t allele carriers of TaqI polymorphism. For VDR FokI polymorphism, increased risks were found in ovarian and skin cancer while decreased risk in glioma in f allele carriers. For VDR ApaI polymorphism, increased risk was observed in basal cell cancer, especially in Asian population in a allele carriers. In conclusion, these results indicated that b allele of BamI polymorphism was a risk factor for cancer susceptibility. Meanwhile, t allele of TaqI polymorphism was a risk factor for oral, breast, and basal cell cancer and a protective factor for prostate cancer. Moreover, f allele of FokI polymorphism was a risk factor for ovarian and skin cancer and a protective factor for glioma. Finally, a allele of ApaI polymorphism was a risk factor for basal cell cancer in Asian population.
      datePublished:2014-01-10T00:00:00Z
      dateModified:2014-01-10T00:00:00Z
      pageStart:4153
      pageEnd:4169
      sameAs:https://doi.org/10.1007/s13277-013-1544-y
      keywords:
         Vitamin D receptor
         VDR
         Polymorphism
         Cancer risk
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-1544-y/MediaObjects/13277_2013_1544_Fig4_HTML.gif
      isPartOf:
         name:Tumor Biology
         issn:
            1423-0380
            1010-4283
         volumeNumber:35
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yeqiong Xu
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bangshun He
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuqin Pan
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiwen Deng
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huiling Sun
            affiliation:
                  name:Nanjing Normal University
                  address:
                     name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rui Li
            affiliation:
                  name:Nanjing Normal University
                  address:
                     name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tianyi Gao
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guoqi Song
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shukui Wang
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Tumor Biology
      issn:
         1423-0380
         1010-4283
      volumeNumber:35
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Nanjing Medical University
      address:
         name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Normal University
      address:
         name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
         type:PostalAddress
      name:Nanjing Normal University
      address:
         name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yeqiong Xu
      affiliation:
            name:Nanjing Medical University
            address:
               name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Bangshun He
      affiliation:
            name:Nanjing Medical University
            address:
               name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Yuqin Pan
      affiliation:
            name:Nanjing Medical University
            address:
               name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Qiwen Deng
      affiliation:
            name:Nanjing Medical University
            address:
               name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Huiling Sun
      affiliation:
            name:Nanjing Normal University
            address:
               name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Rui Li
      affiliation:
            name:Nanjing Normal University
            address:
               name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Tianyi Gao
      affiliation:
            name:Nanjing Medical University
            address:
               name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Guoqi Song
      affiliation:
            name:Nanjing Medical University
            address:
               name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Shukui Wang
      affiliation:
            name:Nanjing Medical University
            address:
               name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
      name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
      name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
      name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
      name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
      name:Department of Life Sciences, Nanjing Normal University, Nanjing, China
      name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
      name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
      name:Central Laboratory of Nanjing First Hospital, Nanjing Medical University, Nanjing, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(247)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Crossref

4.53s.